Valuation: STCube, Inc.

Market Cap 530B 382M 328M 306M 281M 526M 36.58B 533M 3.62B 1.41B 18.38B 1.44B 1.4B 60.78B P/E 2024
-19.4x
P/E 2025 -25.6x
Enterprise Value 472B 341M 292M 273M 250M 469M 32.62B 476M 3.23B 1.26B 16.39B 1.28B 1.25B 54.2B EV / Sales 2024
44.3x
EV / Sales 2025 71.5x
Free-Float
92.57%
Yield 2024 *
-
Yield 2025 -
24-10-23 STCube, Inc. announced that it has received KRW 13.00000464 billion in funding CI
24-08-25 STCube, Inc. announced that it expects to receive KRW 13.00000464 billion in funding CI
24-03-27 STCube, Inc.(KOSDAQ:A052020) dropped from S&P Global BMI Index CI
23-09-06 Global markets live: Apple, Alphabet, Roku, Amazon, General Mills... Zonebourse
23-03-21 STCube, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
22-03-07 STCube to Raise $36 Million via Stock Sale; Shares Surge 10% MT
20-12-27 STCube, Inc. announced that it has received KRW 9.9999921 billion in funding from Newgreen Co. Ltd. and another investor CI
20-12-17 STCube, Inc. announced that it expects to receive KRW 9.9999921 billion in funding from Newgreen Co. Ltd. and another investor CI
20-07-11 Samsung Biologics Signs Additional Development and Manufacturing Agreement with STCube CI
20-03-02 Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug CI
18-05-24 STCube, Inc. announced that it has received KRW 41.999908468 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Shinhan Investment Corp., Samsung Securities Co.,Ltd., Hana Bank, Investment Arm CI
18-04-24 STCube, Inc. announced that it expects to receive KRW 41.999908468 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Shinhan Investment Corp., Samsung Securities Co.,Ltd., Hana Bank, Investment Arm and other investors CI
16-09-19 STCube, Inc.(KOSDAQ:A052020) added to S&P Global BMI Index CI
1 day-7.14%
1 week-15.68%
Current month+8.48%
1 month+7.88%
3 months-49.22%
6 months-11.66%
Current year-4.88%
1 week 7,770
Extreme 7770
9,250
1 month 6,010
Extreme 6010
9,570
Current year 6,010
Extreme 6010
22,500
1 year 6,010
Extreme 6010
22,500
3 years 3,940
Extreme 3940
22,500
5 years 3,940
Extreme 3940
28,500
10 years 3,940
Extreme 3940
28,600
Manager TitleAgeSince
Chief Executive Officer 61 2013-03-28
Director of Finance/CFO 54 -
Chief Tech/Sci/R&D Officer 62 2014-02-28
Director TitleAgeSince
Director/Board Member 61 2013-02-28
Director/Board Member 54 2013-02-28
Director/Board Member 62 2014-02-28
Date Insider Type Main position Quantity % Market Cap.
12/3/24 Buy

Chief Technology Officer

164,014 0.2515%
12/3/24 Buy

Chief Executive Officer

18,346 0.0281%
12/3/24 Buy

Chief Financial Officer

47,582 0.0730%
Change 5-day change 1-year change 3-year change Capi.($)
-7.14%-15.68%+9.86%-44.05% 410M
-0.98%-8.85%+41.37%+34.94% 123B
+5.16%-7.27%+198.76%+829.97% 45.6B
+0.12%-12.45%+123.54%+324.97% 40.75B
+1.00%-5.26%+58.92%+202.23% 36B
+0.35%-6.40%+17.28%+57.30% 29.39B
+1.15%-7.68%+84.27%+100.72% 29.17B
+1.65%+5.20%-6.18%+3.23% 27.91B
+0.98%-4.77%+8.13%+72.91% 17.91B
+2.22%-2.00%+19.45%+37.75% 17.06B
Average +0.45%-6.77%+55.54%+162.00% 36.75B
Weighted average by Cap. +0.81%-6.59%+66.93%+188.66%

Financials

2024 2025
Net sales 11.3B 8.15M 6.98M 6.53M 5.98M 11.22M 780M 11.37M 77.19M 30.1M 392M 30.61M 29.94M 1.3B 6.98B 5.04M 4.32M 4.04M 3.7M 6.94M 482M 7.03M 47.72M 18.61M 242M 18.92M 18.51M 801M
Net income -21.44B -15.47M -13.25M -12.4M -11.35M -21.3M -1.48B -21.58M -146M -57.12M -743M -58.08M -56.82M -2.46B -21.8B -15.73M -13.47M -12.61M -11.54M -21.66M -1.51B -21.94M -149M -58.09M -756M -59.06M -57.78M -2.5B
Net Debt -79.55B -57.4M -49.17M -46.01M -42.11M -79.03M -5.49B -80.08M -544M -212M -2.76B -216M -211M -9.13B -57.42B -41.43M -35.49M -33.21M -30.4M -57.05M -3.96B -57.8M -392M -153M -1.99B -156M -152M -6.59B
Logo STCube, Inc.
STCube Inc is a Korea-based company mainly engaged in the distribution of lens modules and related components. The Company operates its business through two segments. The Distribution segment is engaged in the industrial lens modules and related parts distribution, basic skin care products distribution and Cynthia basic skin care products manufacture and distribution business. The Biotechnology segment is engaged in the research, development and licensing of immunomodulatory anticancer drug therapeutic candidates.
Employees
13
Date Price Change Volume
26-08-21 ₩7,800.00 -7.14% 177,080
26-08-20 ₩8,400.00 -2.33% 184,781
26-08-19 ₩8,600.00 -1.49% 183,465
26-08-18 ₩8,730.00 -5.62% 170,798
26-08-14 ₩9,250.00 -1.39% 149,839
  1. Stock Market
  2. Stocks
  3. A052020 Stock